Search Results for "bismuth subsalicylate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for bismuth subsalicylate. Results 11 to 15 of 15 total matches.
See also: Helidac, PeptoBismol

Sarecycline (Seysara) - Another Oral Tetracycline for Acne

   
The Medical Letter on Drugs and Therapeutics • Mar 25, 2019  (Issue 1568)
be avoided. Administration of sarecycline with bismuth subsalicylate or aluminum-, calcium-, magnesium ...
Sarecycline (Seysara — Allergan), a new oral tetracycline antibiotic, has been approved by the FDA for once-daily treatment of inflammatory lesions of non-nodular moderate to severe acne in patients ≥9 years old.
Med Lett Drugs Ther. 2019 Mar 25;61(1568):43-4 |  Show IntroductionHide Introduction

A Low-Dose Doxycycline (Oracea) for Rosacea

   
The Medical Letter on Drugs and Therapeutics • Jan 15, 2007  (Issue 1252)
INTERACTIONS — Bismuth subsalicylate, proton pump inhibitors, iron, antacids and food can decrease doxycycline ...
A new once-daily, low-dose oral formulation of doxycycline monohydrate (Oracea - CollaGenex) has been approved by the FDA for treatment of inflammatory papules and pustules associated with rosacea in adults.
Med Lett Drugs Ther. 2007 Jan 15;49(1252):5-6 |  Show IntroductionHide Introduction

Omadacycline (Nuzyra) - A New Tetracycline Antibiotic

   
The Medical Letter on Drugs and Therapeutics • May 20, 2019  (Issue 1572)
of bleeding in patients taking an anticoagulant. Ironcontaining products, bismuth subsalicylate ...
The FDA has approved omadacycline (Nuzyra – Paratek), a semisynthetic tetracycline derivative, for once-daily IV and oral treatment of community-acquired bacterial pneumonia (CAP) and acute bacterial skin and skin structure infections (ABSSSIs) in adults.
Med Lett Drugs Ther. 2019 May 20;61(1572):74-7 |  Show IntroductionHide Introduction

Advice for Travelers

   
The Medical Letter on Drugs and Therapeutics • Oct 07, 2019  (Issue 1582)
for malaria prophylaxis, and it has the advantage of once-weekly Bismuth subsalicylate (Pepto-Bismol ...
Patients who receive pretravel advice can reduce their risk for many travel-related conditions. Vaccines recommended for travelers are reviewed in a separate issue.
Med Lett Drugs Ther. 2019 Oct 7;61(1582):153-60 |  Show IntroductionHide Introduction

Management of Opioid Withdrawal Symptoms

   
The Medical Letter on Drugs and Therapeutics • Aug 27, 2018  (Issue 1554)
with bismuth subsalicylate or the gutspecifi c opioid loperamide. Abdominal cramping can be managed ...
Pharmacologic management of opioid withdrawal symptoms can reduce the intensity of drug craving and improve treatment retention in patients with opioid use disorder who will receive maintenance treatment. Withdrawal management without subsequent maintenance treatment is associated with high rates of relapse, overdose death, and HIV and/or hepatitis C virus infection. Several guidelines on management of opioid withdrawal are available. Maintenance treatment of opioid use disorder was reviewed in a previous issue.
Med Lett Drugs Ther. 2018 Aug 27;60(1554):137-42 |  Show IntroductionHide Introduction